Elite Pharmaceuticals, Inc.

“Represented Elite Pharmaceuticals, Inc. (AMEX:ELI), a pharmaceutical company principally engaged in the development of oral, controlled release products, in a private placement of $10 million of Series B Preferred Stock and warrants.
Represented Elite Pharmaceuticals, Inc. (AMEX:ELI), a pharmaceutical company principally engaged in the development of oral, controlled release products, in a private placement of $6.6 million of Series A Preferred Stock.
Represented Edison Venture Fund, a Mid-Atlantic private equity fund specializing in venture capital, management buyout, corporate spinout and recapitalization financings, in connection with its purchase of Series B Preferred Stock of Magnetic Media Online Holdings, Inc., a New York-based digital technology company.”